✉news ScienceBiology first seen 12 h ago, last 12 h ago, peak #22
Cathie Wood's ARKG Biotech Bets Surge Nearly Sixfold This Year
Original: Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
Two biotech holdings in Cathie Wood's ARK Genomic Revolution ETF (ARKG) have surged nearly six times in value this year, making the genomics fund the strongest performer among ARK Invest's lineup of ETFs. The outsized gains from the two biotech positions are driving the fund's advantage over her other products, drawing attention to Wood's high-conviction bets in genomics.
Why now: Investors are reacting to the dramatic outperformance of two biotech stocks in a high-profile fund manager's portfolio.
Cathie WoodARK InvestARKGbiotech
Evidence
- Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year · TradingView
API: https://socialmediatrends-api.osmike.com/v1/trends/1087525